Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer
Condition: Pancreatic Cancer Metastatic Intervention: Drug: C3 (Metformin, Simvastatin, and Digoxin) Sponsor: State University of New York - Downstate Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Fortamet | Metformin | New York University | Pancreas | Pancreatic Cancer | Research | Simvastatin | Statin Therapy | Zocor